Quarterly Quality Indicators
As your partner in caring for the patient’s you serve, we are now providing Quarterly Quality Indicators. Our desire is to make this information available to you to demonstrate quality measurement of our staff, products, and services. We have selected 5 points that reflect these aspects and will provide an update on a quarterly basis.
|
Quarter: |
Fourth |
Year: |
2022 |
Report Date: |
1/25/2023 |
||||||
|
|
|
||||||||||
|
|
1st quarter 2022 |
2nd quarter 2022 |
3rd quarter 2022 |
4th quarter 2022 |
|
||||||
|
|
Yes |
Yes |
Yes |
Yes |
|
||||||
|
Laboratory Proficiency Testing Results – pass rate of 100%
|
¨ |
x |
x |
¨ |
|
||||||
|
Apheresis Platelet Storage Quality Control- pass rate of ≥95%
|
x |
x |
x |
x |
|
||||||
|
Quarterly Blood Component Shipment Temperature Quality Control- no temperature excursions
|
x |
x |
x |
x |
|
||||||
|
Automated Red Blood Cell residual WBC Quality Control – pass rate of ≥95%
|
x |
x |
x |
x |
|
||||||
|
Post-Leukoreduction Red Blood Cell Recovery Quality Control – pass rate of ≥95%
|
x |
x |
x |
x |
|
||||||
Comments: RBC Antigen genotyping 94% for first quarter of 2022. Failed GYB*03 genotype result for CAP sample RAG-B, RAG-04. The expected result was GYPB*03/03. LinkSeq reported the result as GYPB*03/04. Repeat testing on alternative assay yielded expected result. Sample was then repeated on original assay and correct result was obtained. The assay manufacturer is unable to explain why the assay gave an incorrect call on the original test.
4th quarter 2022 One of the 2 DAT samples for C3 testing was reported as positive. Intended result was negative.